Wird geladen...
A pilot clinical trial with losartan in Myhre syndrome
INTRODUCTION: Myhre syndrome (MS) is an ultra‐rare disorder due to pathogenic variants in the SMAD4 gene that encodes a protein regulating the TGF‐β pathway and extra‐cellular matrix (ECM) homeostasis. Main clinical features of MS include thickening of skin and joint stiffness. Previous studies show...
Gespeichert in:
| Veröffentlicht in: | Am J Med Genet A |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898344/ https://ncbi.nlm.nih.gov/pubmed/33369056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajmg.a.62019 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|